Exploring the Potential of 7,4'-di(diethylamino)flavylium As a Novel Photosensitizer for Topical Photodynamic Therapy of Skin Cancer

Overview

Journal Sci Rep

Specialty Science

Date 2024 Nov 28

PMID 39604502

Authors

Patricia Correia

Paula Araujo

Joana Marto

Helena Ribeiro

Nuno Mateus

Victor de Freitas

Joana Oliveira

Iva Fernandes

Affiliations

Soon will be listed here.

Abstract

Photodynamic therapy (PDT) is a minimally invasive therapeutic approach that has shown promising results in recent years, particularly in the dermatological clinical treatment of several pathologies, including neoplastic skin diseases. In light of the recent discovery of the photosensitizing properties of a water-soluble group of amino-based flavylium dyes, research efforts have led to the development of a novel synthetic dye with two diethylamino moieties in its structure, 7,4'-di(diethylamino)flavylium (7,4'diN(Et)). This dye was tested as a potential photosensitizer for PDT of skin cancer. A single light dose of 22.5 J/cm efficiently killed SCC-25 (squamous cell carcinoma) and A375 (melanoma) cells, reducing cellular viability by more than 80% in the presence of the flavylium at 0.75 µM. Meanwhile, the negligible cellular toxicity of the dye in the absence of light stimulus points out a wide and safe therapeutic window. Interestingly, significant light-induced toxicity effects were still observed after washing out the compound before cell irradiation. Moreover, out of the three prototype flavylium-loaded hydrogels, each one based on a different polymer (Carbomer, Caesalpinia Spinosa Gum and Hydroxypropyl methyl cellulose), carbomer-based formulation stood out for its substantial absorbance and fluorescence increment and enhancedO photogeneration activity compared to the flavylium in aqueous solution. The findings of this study provide valuable insights concerning the potential of this flavylium dye as a candidate for photodynamic therapy of skin cancer and strongly support the need for further testing in more advanced biological settings to fully assess its efficacy and safety.

References

Li Y, Han W, Gong D, Luo T, Fan Y, Mao J . A self-assembled nanophotosensitizer targets lysosomes and induces lysosomal membrane permeabilization to enhance photodynamic therapy. Chem Sci. 2023; 14(19):5106-5115. PMC: 10189857. DOI: 10.1039/d3sc00455d. View

Itoo A, Paul M, Padaga S, Ghosh B, Biswas S . Nanotherapeutic Intervention in Photodynamic Therapy for Cancer. ACS Omega. 2022; 7(50):45882-45909. PMC: 9773346. DOI: 10.1021/acsomega.2c05852. View

Goncalves R, Belmonte-Reche E, Pina J, Costa Da Silva M, Pinto S, Gallo J . Bioimaging of Lysosomes with a BODIPY pH-Dependent Fluorescent Probe. Molecules. 2022; 27(22). PMC: 9696654. DOI: 10.3390/molecules27228065. View

Celli J, Spring B, Rizvi I, Evans C, Samkoe K, Verma S . Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev. 2010; 110(5):2795-838. PMC: 2896821. DOI: 10.1021/cr900300p. View

Pina F, Melo M, Laia C, Parola A, Lima J . Chemistry and applications of flavylium compounds: a handful of colours. Chem Soc Rev. 2011; 41(2):869-908. DOI: 10.1039/c1cs15126f. View

Glass S, Rudiger T, Griebel J, Abel B, Schulze A . Uptake and release of photosensitizers in a hydrogel for applications in photodynamic therapy: the impact of structural parameters on intrapolymer transport dynamics. RSC Adv. 2022; 8(72):41624-41632. PMC: 9092030. DOI: 10.1039/c8ra08093c. View

Ran P, Xia T, Zheng H, Lei F, Zhang Z, Wei J . Light-triggered theranostic hydrogels for real-time imaging and on-demand photodynamic therapy of skin abscesses. Acta Biomater. 2022; 155:292-303. DOI: 10.1016/j.actbio.2022.11.039. View

Lu P, Ruan D, Huang M, Tian M, Zhu K, Gan Z . Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions. Signal Transduct Target Ther. 2024; 9(1):166. PMC: 11214942. DOI: 10.1038/s41392-024-01852-x. View

Gan S, Wu Y, Zhang X, Zheng Z, Zhang M, Long L . Recent Advances in Hydrogel-Based Phototherapy for Tumor Treatment. Gels. 2023; 9(4). PMC: 10137920. DOI: 10.3390/gels9040286. View

10.

Hamed E, Al Balah O, Refaat M, Badr A, Afifi A . Photodynamic therapy mediated by methylene blue-loaded PEG accelerates skin mouse wound healing: an immune response. Lasers Med Sci. 2024; 39(1):141. PMC: 11129982. DOI: 10.1007/s10103-024-04084-1. View

11.

Lima E, Reis L . Photodynamic Therapy: From the Basics to the Current Progress of -Heterocyclic-Bearing Dyes as Effective Photosensitizers. Molecules. 2023; 28(13). PMC: 10343694. DOI: 10.3390/molecules28135092. View

12.

Rodrigues J, Correia J . Enhanced Photodynamic Therapy: A Review of Combined Energy Sources. Cells. 2022; 11(24). PMC: 9776440. DOI: 10.3390/cells11243995. View

13.

Park J, Lee Y, Park I, Hwang S . Current Limitations and Recent Progress in Nanomedicine for Clinically Available Photodynamic Therapy. Biomedicines. 2021; 9(1). PMC: 7830249. DOI: 10.3390/biomedicines9010085. View

14.

Glass S, Kuhnert M, Lippmann N, Zimmer J, Werdehausen R, Abel B . Photosensitizer-loaded hydrogels for photodynamic inactivation of multirestistant bacteria in wounds. RSC Adv. 2022; 11(13):7600-7609. PMC: 8694937. DOI: 10.1039/d0ra09786a. View

15.

Cruz L, Basilio N, Mateus N, de Freitas V, Pina F . Natural and Synthetic Flavylium-Based Dyes: The Chemistry Behind the Color. Chem Rev. 2021; 122(1):1416-1481. DOI: 10.1021/acs.chemrev.1c00399. View

16.

Gomes R, Parola A, Laia C, Pina F . Promoting photochromism on flavylium derived 2-hydroxychalcones in aqueous solutions by addition of CTAB micelles. J Phys Chem B. 2007; 111(42):12059-65. DOI: 10.1021/jp073859c. View

17.

Sun J, Zhao H, Fu L, Cui J, Yang Y . Global Trends and Research Progress of Photodynamic Therapy in Skin Cancer: A Bibliometric Analysis and Literature Review. Clin Cosmet Investig Dermatol. 2023; 16:479-498. PMC: 9961166. DOI: 10.2147/CCID.S401206. View

18.

Penetra M, Arnaut L, Gomes-da-Silva L . Trial watch: an update of clinical advances in photodynamic therapy and its immunoadjuvant properties for cancer treatment. Oncoimmunology. 2023; 12(1):2226535. PMC: 10281486. DOI: 10.1080/2162402X.2023.2226535. View

19.

Oliveira H, Araujo P, Pereira A, Mateus N, de Freitas V, Oliveira J . Photoactivated cell-killing amino-based flavylium compounds. Sci Rep. 2021; 11(1):22005. PMC: 8578629. DOI: 10.1038/s41598-021-01485-y. View

20.

OConnor A, Gallagher W, Byrne A . Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol. 2009; 85(5):1053-74. DOI: 10.1111/j.1751-1097.2009.00585.x. View